Literature DB >> 32401951

OUTLET OBSTRUCTED CONSTIPATION AND FECAL INCONTINENCE: IS REHABILITATION TREATMENT THE WAY? MYTH OR REALITY.

Luigi Brusciano1, Claudio Gambardella1,2, Gianmattia Del Genio1, Salvatore Tolone1, Francesco Saverio Lucido1, Gianmattia Terracciano1, Giorgia Gualtieri1, Ludovico Docimo1.   

Abstract

Pelvic floor rehabilitation aims to address perineal functional and anatomic alterations as well as thoraco-abdominal mechanic dysfunctions leading to procto-urologic diseases like constipation, fecal and urinary incontinence, and pelvic pain. They require a multidimensional approach, with a significant impact on patients quality of life. An exhaustive clinical and instrumental protocol to assess defecation disorders should include clinical and instrumental evaluation as well as several clinical/physiatric parameters. All these parameters must be considered in order to recognize and define any potential factor playing a role in the functional aspects of incontinence, constipation and pelvic pain. After such evaluation, having precisely identified any thoraco-abdomino-perineal anatomic and functional alterations, a pelvi-perineal rehabilitation program can be carried out to correct the abovementioned alterations and to obtain clinical improvement. The success of the rehabilitative process is linked to several factors such as a careful evaluation of the patient, aimed to select the most appropriate and specific targeted rehabilitative therapy, the therapist's scrupulous hard work, especially as regards the patient's emotional and psychic state, and finally the patient's compliance in undertaking the therapy itself, especially at home. These factors may deeply influence the overall outcomes of the rehabilitative therapies, ranging from "real" success to illusion "myth".

Entities:  

Year:  2020        PMID: 32401951     DOI: 10.1590/s0004-2803.202000000-38

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  1 in total

1.  Pelvic floor physical therapy in patients with chronic anal fissure: a randomized controlled trial.

Authors:  Daniëlle A van Reijn-Baggen; Henk W Elzevier; H Putter; Rob C M Pelger; Ingrid J M Han-Geurts
Journal:  Tech Coloproctol       Date:  2022-05-05       Impact factor: 3.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.